Journal
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
Volume 18, Issue 4, Pages 368-395Publisher
CANADIAN SOC PHARMACEUTICAL SCIENCES
DOI: 10.18433/J3BK5T
Keywords
-
Categories
Funding
- University of Manitoba
- Manitoba Pharmaceutical Association (MPhA)/William G. Eamer Graduate Scholarship in Pharmacy
- Kuwait University
Ask authors/readers for more resources
Purpose: Delineate the stereospecific pharmacokinetics and pharmacodynamics of the chiral flavonoids pinocembrin and pinostrobin. Objective: Characterize for the first time the stereoselective pharmacokinetics of two flavonoids, pinocembrin and pinostrobin and their bioactivity in several in vitro assays with relevant roles in heart disease, colon cancer, and diabetes etiology and pathophysiology. Methods: Chiral flavonoids were intravenously and orally administered to male Sprague-Dawley rats. Concentrations in serum and urine were characterized via stereospecific HPLC or LC/MS. Pure enantiomeric forms of each flavonoid were tested, where possible, to identify the stereospecific contribution to bioactivity in comparision to their racemates. Results: Short half-lives (0.2-6 h) in serum were observed, while a better estimation of half-life (326 h) and other pharmacokinetic parameters were observed using urinary data. The flavonoids are predominantly excreted via non-renal routes (f(e) values of 0.3-4.6 %), and undergo rapid and extensive phase II metabolism. Chiral differences in the chemical structure of these compounds result in significant pharmacodynamic differences. Conclusion: The importance of understanding the stereospecific pharmacokinetics and pharmacodynamics of two chiral flavonoids were delineated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available